Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
melanoma
|
352 | 0.641 | 0.520 | 1 | 114713907 | missense variant | TT/CA;CC | mnv | 0.800 | 1.000 | 16 | 1989 | 2019 | ||||||
Neoplasms
|
1571 | 0.641 | 0.520 | 1 | 114713907 | missense variant | TT/CA;CC | mnv | 0.100 | 1.000 | 11 | 2011 | 2019 | ||||||
Metastatic melanoma
|
22 | 0.641 | 0.520 | 1 | 114713907 | missense variant | TT/CA;CC | mnv | 0.030 | 1.000 | 3 | 2015 | 2016 | ||||||
Congenital melanocytic nevus
|
5 | 0.641 | 0.520 | 1 | 114713907 | missense variant | TT/CA;CC | mnv | 0.020 | 1.000 | 2 | 2016 | 2017 | ||||||
Follicular thyroid carcinoma
|
28 | 0.641 | 0.520 | 1 | 114713907 | missense variant | TT/CA;CC | mnv | 0.020 | 1.000 | 2 | 2016 | 2018 | ||||||
Thyroid Neoplasm
|
114 | 0.641 | 0.520 | 1 | 114713907 | missense variant | TT/CA;CC | mnv | 0.020 | 1.000 | 2 | 2016 | 2017 | ||||||
Acute lymphocytic leukemia
|
211 | 0.641 | 0.520 | 1 | 114713907 | missense variant | TT/CA;CC | mnv | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||||
Adult Diffuse Large B-Cell Lymphoma
|
42 | 0.641 | 0.520 | 1 | 114713907 | missense variant | TT/CA;CC | mnv | 0.010 | 1.000 | 1 | 1997 | 1997 | ||||||
B-CELL MALIGNANCY, LOW-GRADE
|
19 | 0.641 | 0.520 | 1 | 114713907 | missense variant | TT/CA;CC | mnv | 0.010 | 1.000 | 1 | 1997 | 1997 | ||||||
Carcinoma of lung
|
995 | 0.641 | 0.520 | 1 | 114713907 | missense variant | TT/CA;CC | mnv | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||||
Carcinoma, Papillary
|
9 | 0.641 | 0.520 | 1 | 114713907 | missense variant | TT/CA;CC | mnv | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
Chronic Lymphocytic Leukemia
|
125 | 0.641 | 0.520 | 1 | 114713907 | missense variant | TT/CA;CC | mnv | 0.010 | 1.000 | 1 | 1997 | 1997 | ||||||
Colorectal Carcinoma
|
1186 | 0.641 | 0.520 | 1 | 114713907 | missense variant | TT/CA;CC | mnv | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||
Congenital chromosomal disease
|
47 | 0.641 | 0.520 | 1 | 114713907 | missense variant | TT/CA;CC | mnv | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
Differentiated Thyroid Gland Carcinoma
|
72 | 0.641 | 0.520 | 1 | 114713907 | missense variant | TT/CA;CC | mnv | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||
Diffuse Large B-Cell Lymphoma
|
109 | 0.641 | 0.520 | 1 | 114713907 | missense variant | TT/CA;CC | mnv | 0.010 | 1.000 | 1 | 1997 | 1997 | ||||||
Dysplastic Nevus
|
7 | 0.641 | 0.520 | 1 | 114713907 | missense variant | TT/CA;CC | mnv | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
Familial Hypophosphatemic Rickets
|
14 | 0.641 | 0.520 | 1 | 114713907 | missense variant | TT/CA;CC | mnv | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||
Follicular Variant Thyroid Gland Papillary Carcinoma
|
13 | 0.641 | 0.520 | 1 | 114713907 | missense variant | TT/CA;CC | mnv | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||
Hypophosphatemic Rickets
|
3 | 0.641 | 0.520 | 1 | 114713907 | missense variant | TT/CA;CC | mnv | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||
Invasive Cutaneous Melanoma
|
7 | 0.641 | 0.520 | 1 | 114713907 | missense variant | TT/CA;CC | mnv | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||
Juvenile Myelomonocytic Leukemia
|
26 | 0.641 | 0.520 | 1 | 114713907 | missense variant | TT/CA;CC | mnv | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||||
Malignant neoplasm of thyroid
|
103 | 0.641 | 0.520 | 1 | 114713907 | missense variant | TT/CA;CC | mnv | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||||
Malignant Neoplasms
|
1441 | 0.641 | 0.520 | 1 | 114713907 | missense variant | TT/CA;CC | mnv | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
Neoplasm Metastasis
|
327 | 0.641 | 0.520 | 1 | 114713907 | missense variant | TT/CA;CC | mnv | 0.010 | 1.000 | 1 | 2017 | 2017 |